In 2014 the state of Ohio was #2 for most overdose deaths in all of America with approximately 2,744 deaths. For 2016 early estimates are putting that number at 4,149 Ohioans who lost their lives, a 36% climb from 2015, the year when the Buckeye State had by far the most overdose deaths in the nation.
On average, 11 people died every day from heroin, fentanyl, carfentanil and other drugs in Ohio through 2016.
As the nation grapples with these skyrocketing body counts from coast to coast, more government and law enforcement officials are trying to find new ways to take action against the opioid crisis. For those who do not know, fentanyl is a synthetic opioid; one of the most dangerous drugs on the illicit market.
But recently the Capital City of the Midwest has scored a huge win in that fight.
Enough to Kill Columbus
Back in October one drug bust led to investigators discovering 2 kilograms, or 4.5 pounds, of fentanyl in the trunk of a car. To put this in perspective, the Franklin County Prosecutor Ron O’Brien stated that:
- A fatal dose of fentanyl is considered to be only 2-3 milligrams.
- In Columbus, Ohio the population is approximately 860,000 people.
Crunching the numbers, the prosecutor points out this amount of the incredibly lethal synthetic drug could have killed every man, woman, and child in the city.
Three California men were arrested in relation to this bust.
Enough to Kill Ohio
Just when you think you’ve heard the worst of it, that’s not even the tip of the iceberg. The following month police in the capital city seized 20 pounds of pure fentanyl. In regards to this case, Ron O’Brien said,
“So it would probably be enough to kill all, the entire population in the state of Ohio.”
Again, using the same lethal fentanyl dosage for perspective, Ohio has 11.6 million residents. The amount of fentanyl discovered in the November bust could potentially kill more than 9 million people. O’Brien included,
“Two or three milligrams of fentanyl is not much more than five or six small grains of salt.”
So it stands to reason that 20 pounds of this drug could easily wipe out the vast majority of the inhabitants of the state.
More Record Busts this Year
The opioid epidemic is the greatest drug crisis in the history of the country. As the problem has intensified, the spread of fentanyl and carfentanil has continued to bring dead and devastation. Luckily, there are more major opioid busts this year, with some seizing enough fentanyl to kill entire populations of several states.
In August officials of the Empire State managed to seize more than 140 pounds of fentanyl in August. The Drug Enforcement Administration said that amount could’ve killed nearly 32 million people. Put more bluntly, this amount of fentanyl could wipe out the populations of Texas and Oklahoma… combined!
Back in June officials in this major California city found close to 100 pounds of fentanyl. That is enough to kill 22.4 million people; that is the combined populations of:
- New York
- New Hampshire
The Gateway to the West was able to catch nearly 60 pounds of pure fentanyl back in April. That alone is enough to kill more than 13.6 million people.
Fighting the Spread of Fentanyl
Back in Ohio, Ron O’Brien and other officials know the opioid epidemic is getting worse all over the country. The Center for Disease Control and Prevention’s latest drug report states:
- More than 33,000 people died from opioid-related drug overdoses in 2015
- Close to 10,000 of them were from synthetic opioids such as fentanyl
In the state of Ohio, the opioid crisis has placed an increasing strain on resources. Financially it is costing Ohio residents between $6.6 and 8.8 billion per year, according to some experts. That is almost as much as the state spends on education for grades K-12.
Yet the fight goes on.
These massive seizures of this lethal synthetic chemical have undoubtedly saved many lives. However, putting a complete stop to the illicit drug trade is still very far off, if at all possible. Still, taking a few hundred pounds of such a potent and potentially deadly drugs off the streets makes an immeasurable difference.
For more important information on the dangers of prescription drugs, download our FREE E-BOOK “Big Secrets of Big Pharma: Why They Secretly Hope You Get Hooked”
DOWNLOAD FREE E-BOOK
Treating Opioid Abuse
Holistic drug addiction treatment is an effective and important resource for helping people struggling with substance use disorder, especially in the wake of the opioid crisis in America.
Outbreaks of more life-threatening drug problems including fentanyl and other hazardous synthetics only make the need for supportive and impactful treatment more relevant. If we want to overcome the opioid epidemic there must be an emphasis on how we treat people struggling and on how we support them through the recovery process.
Treating opioid abuse is about building a strong foundation with safe medical detox, personalized therapy, and innovative treatment opportunities. Palm Healthcare Company helps thousands of people all over the country overcome opioid abuse. Our facilities are committed to providing quality care for those dealing with drug abuse, whether it is illicit drugs or prescription drug dependence. If you or someone you love is struggling, please call toll-free now. We want to help.
CALL NOW 1-888-922-5398
This past Wednesday, Attorney General Jeff Sessions made the announcement that White House counselor Kellyanne Conway will be the Trump administration’s go-to for opioid crisis efforts. This announcement has been met with both praise and criticism. Some say this appointment actually gives validity to the White House’s commitment to solving the ongoing opioid epidemic, while others see it as the exact opposite.
For a little background, Kellyanne Conway worked as a pollster before becoming Trump’s campaign manager during his run for the 2016 presidential nomination. Currently, Conway serves as a White House spokeswoman and Trump surrogate. She has been seen on countless panels discussing the biggest topics and politics. She absolutely has her work cut out for her, so can Kellyanne Conway compete?
The Kellyanne Cons and Pros
So can this infamous Trump advocate, the woman who practically accidentally coined the phrase “alternative facts” compete with the opioid crisis in America? Kallyanne Conway has become notorious for defending some of President Trump’s most flagrant and controversial “alternative facts” in the media. But in her defense, she also has said some things that seem to highlight important prospects for this problem.
So here are some things to consider when we talk about Kellyanne Conway being put in charge of the opioid epidemic.
Lack of Experience
One of the big problems with this appointment people are pointing out is the lack of experience. Critics say this appointment speaks to how little passion the current administration is actually putting into fighting the opioid crisis since Kellyanne Conway has no experience in public health or with drug policy.
But in a time where Americans seem to be putting more trust in people that don’t typically meet the description of “qualified” in hopes that an outsider might bring better results, it makes sense that a lot of people might still hope Kellyanne can do some good.
Yet, there are still those who aren’t so sure. Tom Synan, a police chief and member of the Hamilton County Heroin Coalition in Ohio tweeted in response to the announcement:
“Ummm… did we run out of Dr’s, cops, addiction specialists or people who are actually dealing with this on the street to lead this?”
As a first responder, Synan is one of many people who are frustrated with the current actions being taken.
“I don’t want to get involved in politics, but it seems like it is a political position … I think I would have gone out to the country and tapped into people who are national experts who are on the street who are literally dealing with this issue every day,”
It seems many on the front lines are not impressed with the Trump administration’s move to put Kellyanne Conway in charge of efforts to combat one of the worst drug problems in the nation’s history.
Publicity and Perception
During a press briefing about the Justice Department’s efforts to combat the crisis where the announcement was made, Sessions said President Donald Trump chose Kellyanne Conway to “change the perception” about opioids and reduce addictions and deaths.
According to Sessions, President Trump has made the epidemic “a top priority for his administration, including every senior official and Cabinet member.”
An opioid policy expert Andrew Kolodny of Brandeis University actually defended the move when speaking to BuzzFeed News, stating:
“It is a positive sign. She is a high-profile figure in the administration, showing the administration takes this seriously,”
Some believe this can offer a sign of hope for more concrete action since many recovery advocates say despite the declaration of a public health emergency from President Trump there has been very little action taken to change the state of the epidemic.
Bertha Madras, a member of the President’s Commission on Combating Drug Addiction and the Opioid Crisis and Harvard Medical School professor, said:
“The most important thing that Kellyanne Conway will provide is access … but also commitment… She was at all the meetings, she listened and took copious notes.”
Let’s hope those are some good notes because thus far the opioid problem in America has shown no signs of slowing down. Jeff Sessions justified the appointment by saying Kellyanne Conway “understanding messaging” and can help turn around public perception. But is this about publicity, or is it about the preservation of life?
Surely breaking the stigma and changing the way addiction is viewed does matter, but should someone who specializes in making things look good to be in charge of how this country deals with one of the most prominent crises we face?
Treatment and Resources
Kellyanne does seem to support treatment, but to what extent it is still unclear. In one interview with ABC Kellyanne Conway did say,
“Pouring money into the problem is not the only answer. We have to get serious about in-facility treatment and recovery.”
So she at least appears to understand how crucial effective inpatient treatment is for recovery.
But when reporters mentioned the fact that there needs to be funding for these programs, she put more emphasis on “a 4 letter word called will” that seems to side-step the question- where will these resources come from?
As it now stands, White House has:
- Left the leadership role of the Office of National Drug Control Policy vacant
- Failed to release any written opioid-control strategy
- Not requested funds to replenish the national public health emergency fund that currently sits at just $66,000
In fact, President Trump’s 2018 budget request would increase addiction treatment funding by less than 2%. And don’t be fooled, that increase includes the $500 million already appropriated by Congress in 2016 under the 21st Century Cures Act with the Obama administration.
Even Chris Christie, the Republican New Jersey Governor who led the White House Opioid Commission, said:
“In New Jersey, we are spending $500 million,” he said. “I am not, quite frankly, impressed with $1 billion from the federal government for the nation.”
Strict Prevention and Punishment
When you look at what she has said on record in regards to opioids and addiction, it doesn’t really inspire a great deal of confidence. Kellyanne Conway has consistently hinted to an outdated ideology of what addiction is and how to address it.
In the past, Kellyanne has said,
“The best way to stop people dying from overdoses and drug abuse is by not starting in the first place… That’s a big core message for our youth.”
That’s right; just say no.
Critics say this aligns with the mindset of Jeff Sessions and others in the White House who seem to think that ‘Just Say No’ tactics actually work, or that purely prevention-based programs like D.A.R.E. can solve the whole problem. While prevention is important, it has proven to be ineffective as a focal point when addressing addiction.
Circling back to publicity, what Ms. Conway does seem to heavily endorse is a White House investigation for a “national ad campaign” on abuse prevention. President Trump himself had voiced his own support for a national advertising initiative to try and deter drug use.
But we all remember those commercials- this is your brain on drugs- and they didn’t really help that much.
Again, it seems Attorney General Sessions and the current administration is more focused on punishment than treatment and strict law enforcement. Sessions said the Justice Department was giving more than $12 million in grants to state and local law enforcement to help them prosecute crimes connected to:
Sessions is also ordering all U.S. Attorney offices to designate opioid coordinators. Kaitlyn Boecker, Policy Manager with the Drug Policy Alliance, has been vocal in her disapproval of the current steps being taken.
“Despite declaring the opioid overdose crisis a public health emergency just last month, the Trump Administration continues to emphasize failed prohibitionist policies while ignoring proven public health measures that we know reduce overdose death, like community naloxone distribution.”
“As we feared, the Administration is using the overdose crisis as an excuse to ratchet up the war on drugs rather than an opportunity to save lives.”
At this point, we can say that the news is not without skeptics. While many are still trying to remain hopeful that maybe because Kellyanne is so vocal and such a well-known surrogate for the president that perhaps she will be able to garner more attention to the issue.
While the fight for more resources continues, we should always encourage people to seek help. There are many safe and effective treatment resources already that have been helping people recover from drug and alcohol addiction for decades, like Palm Healthcare Company. If you or someone you love is struggling, please call toll-free now. We want to help.
CALL NOW 1-888-922-5398
The Big Pharma industry is still in the hot seat, and this week another lawmaker is adding a new name to the roster of drug makers to be investigated for shady marketing practices. Alkermes, the company behind the opioid treatment implant Vivitrol, is now being investigated for how they market their product.
Background on Vivitrol
Vivitrol is another name given to the generic drug Naltrexone. Originally approved by the U.S. Food and Drug Administration (FDA) for the treatment of alcohol dependence in 1994, Naltrexone eventually became approved for the treatment of opioid dependence. The medications primary use appears to be blocking the opiate receptors in the brain. It’s intended so that someone using heroin or other opiate-based drugs cannot experience the drugs high.
The Vivitrol shot is made by Boston-based biotech Alkermes. This medication stood out from other Naltrexone medications because Vivitrol is an injection given every 4 weeks with a monthly doctor visit. It is time released for longer lasting relief, instead of being a pill taken once a day.
Supposedly Vivitrol is intended to further help by reducing cravings for opioids. However, Naltrexone and Vivitrol have been refuted by many for having any notable effect on opioid cravings.
Enter Senator Harris
Kamala Harris is a Democratic California Senator who has announced she will be part of launching a new investigation into the sales and marketing practices of the makers of Vivitrol. According to the senator, Alkermes allegedly worked to increase sales of their opioid treatment medication through two questionable strategies:
“Aggressively” marketing Vivitrol to officials in the criminal justice system
Senator Harris says that Alkermes pushes for judges and lawmakers to use their product. The company even provided free samples, which resulted in Vivitrol being actively implemented in 450 treatment programs across 39 states.
Lobbying efforts by federal and state lawmakers
In her statement, Harris also alleges that the company has spent millions of dollars in direct appeals to government officials. Meanwhile, they were contributing to numerous congressional campaigns.
Due to the drug companies marketing, Vivitrol raked in well over $69 million dollars in the third quarter of 2017.
In her statement Senator Harris says,
“We are at the height of a crisis, and companies are taking advantage of pain in order to profit”
“We must hold these companies accountable for their deliberate actions that magnify the opioid epidemic and drive up the cost of drugs for Americans.”
The senator even quoted the chief of addiction medicine at Stanford University School of Medicine, Dr. Anna Lembke, who said,
“Alkermes has taken unethical drug promotion to new depths by enlisting judges, law enforcement personnel, and legislators to favor Vivitrol over proven treatments. Alkermes’ actions undermine public health.”
Which seems like some pretty strong words. In the midst of the opioid crisis, it might be fair to say we should use every resource we can get. However, the Big Pharma enterprises still need to be put in check when it comes to overlooking more effective treatments.
In fact, a 2011 review of studies suggested that Naltrexone was not significantly superior to placebo, and the authors believed there was no sufficient evidence to support Naltrexone therapy for opioid dependence.
One reason Senator Harris seems to have Vivitrol in the crosshairs seems to be that the pharmaceutical company made a habit out of promoting Vivitrol as a more effective treatment than other maintenance drugs, such as Suboxone or Methadone, even though there is no substantive data to support this claim.
As part of the investigation, Harris contacted Richard Pops, the Alkermes Chairman, requesting the company provide data and communication. At the moment Alkermes is disputing the allegations. Senator Harris appears to be calling their bluff, as she was requested that Alkermes submit:
Alkermes has also been asked to turn over any materials provided to participants or speakers for Alkermes since 2010. They’re being asked to disclose amounts paid to the company by various associations, including:
American Society of Addiction Medicine
National Institute on Drug Abuse (NIDA)
Partnership for Drug-Free Kids
Any studies presented to these groups are also to be turned in.
In their own statement, Alkermes states they are “focused on ensuring that patients, healthcare professionals, and criminal justice officials are educated on Vivitrol, and believes that patients should have access to all medications.”
There is no telling whether or not this investigation is going to turn into a witch hunt or if it will blow the lid off of even more bad behavior from Big Pharma. While other drug companies that can be connected to the opioid crisis are already facing lawsuits and others even criminal cases for racketeering and fraud, the Vivitrol producers might find themselves on the chopping block sooner rather than later.
There is already much disagreement about whether or not the Vivitrol treatment is really effective in the first place. Some say the medication helped save their life. Many others have horror stories of uncomfortable side-effects made worse by cravings. Either way, pharmaceutical companies still need to be held accountable for their marketing methods, especially when they seem a little suspect.
For now, this is all a request. Only Republican Senator Ron Johnson has the power to issue subpoenas on behalf of the Homeland and Governmental Affairs Committee.
When talking about the most effective treatment programs for addiction, we should also remember that maintenance drugs like Suboxone, Vivitrol and others are not exactly a solution. While they can be effective in keeping people alive and helping to overcome their sickness, the real healing does not come from magic pills or implants. The real transformation comes with developing the understand and the tools to take care of yourself. If you or someone you love is struggling, please call toll-free now.
CALL NOW 1-888-922-5398
All day people all over the country have been waiting for President Trump to make his formal announcement of the opioid epidemic as a national emergency. Finally, the time for the event at the White House has come, but the announcement has some wondering if enough is being said. So we want to take a little bit of time to talk about some of the highlights from the president’s announcement.
President Donald Trump did give a detailed speech regarding many efforts that are being pursued to combat the opioid epidemic in America. Yet, some are saying that he didn’t say enough about how these resources would be funded, pointing out his declaration was for a Public Health Emergency.
So what does it all mean? Why does the difference matter?
Public Health VS National Disaster
To be clear, both are forms of national emergency declarations. What is the big deal? Well, the difference is the scope and funding that comes with address each order. So today, President Trump, through the Public Health Services Act, directed his acting secretary of health and human services to declare a national health emergency. According to a senior White House official, this designation that will not automatically allocate additional federal funding for the crisis.
If the president has utilized the Stafford Disaster Relief and Emergency Assistance Act, otherwise calling the opioid epidemic a national disaster, the federal government would have been able to immediately tap into funds from the Federal Emergency Management Agency’s Disaster Relief Fund to combat opioids.
Some may say this move was made since the Stafford Act is traditionally used for natural disaster relief, such as with recent Hurricanes Harvey, Irma and Maria. President Trump and President Obama’s administration officials both say that using the Stafford Act would have been too broad and put an unwarranted burden on the Federal Emergency Management Agency’s Disaster Relief Fund. Which seems somewhat likely, since this fund is already being depleted by recovery efforts from the three major hurricanes that hit the United States this year.
Overall, it seems many officials from this and the previous administration feel that a Public Health Emergency was a more appropriate choice out of the two.
What Will Public Health Emergency Do?
The order from President Trump will do some good, including:
- Expanding access to telemedicine to get treatment for those in rural areas
- Instructing agencies to limit bureaucratic delays for dispensing grant money
- Secure Department of Labor grants for the unemployed
- Shift funding for HIV and AIDs programs to provide more substance abuse treatment for people already eligible
- Expands Narcan access
The nationwide health emergency that Trump ordered is more direct but comes with less immediate action.
According to Senior White House officials, they will be following up by working with Congress to get more money for the Public Health Emergency Fund. Which is a good start, since critics are quick to point out there is only $57,000 in this fund.
It is also said to increase federal funding in year-end budget deals currently being negotiated in Congress. In fact, Democratic Pennsylvania Senator Bob Casey introduced a bill this week that would provide $45 billion for opioid abuse prevention, surveillance, and treatment over 10 years. But will it ever see the light of day?
The President Trump Plan: Pros
There were various parts of the speech from President Trump that did hint at some interesting ideas. Some pros and some cons include:
Expanding Treatment Options
Possibly one of the bigger moves here is that President Trump said his administration would also be working to reduce regulatory barriers that prevent people from getting treatment, such as one that bars Medicaid from paying for addiction treatment in residential rehab facilities larger than 16 beds.
If the president can remove some of these hurdles, more people may have access to better options for treatment.
National Institute of Health has taken the first steps of instituting a public-private partnership that will be working toward research and resources including:
- New treatment for addiction
- New treatment for overdose
The president also said,
“We are already distributing nearly $1 billion in grants for addiction prevention and treatment. And over $50 million to support law enforcement programs that assist those facing prison and facing addiction.”
For one, Trump said that the Department of Justice is bringing indictments against Chinese drug traffickers responsible for bringing deadly synthetic opioids like fentanyl into the country.
Another interesting announcement made by President Trump is that the federal government will soon be bringing major lawsuits against people and companies that are involved in the overprescribing and other shady practices concerning prescription drugs.
Pulling Dangerous Prescription Drugs
Trump also says the FDA is now requiring drug companies that manufacture one high-risk opioid, Opana ER, be withdrawn from the market immediately. He states,
“We are requiring that specific opioid, which is truly evil, to be taken off the market immediately.”
President Trump also states his administration will also be pushing for the development of non-addict pain medications.
The President Trump Plan: Cons
President Trump did in many cases acknowledge some useful aspects of combatting the epidemic. But, there were also some ideas that continue to fall short of innovative.
President Trump is also emphasizing the use of a “Massive advertising campaign” to keep young people from doing drugs in the first place. President Trump said-
“- they will see the devastation and ruination it causes to people and people’s lives.”
“The fact is if we can teach young people, and people generally, not to start, it’s really, really easy not to take them. And I think that’s going to end up being our most important thing. Really tough, really big, really great advertising.”
While prevention and education are extremely important, many criticize this strategy saying that these old tactics of “Just Say No” and the D.A.R.E. program just don’t work. This advertising might have been useful if focused on treatment options, but if it is more of the scare tactics of “Refer Madness” then we probably won’t see much improvement.
The Commander in Chief also took this opportunity to promote the building of the wall between the United States and Mexico, stating:
“90% of the heroin in America comes from south of the border, where we will be building the wall, which will be greatly helping this problem!”
He took time in his speech to highlight the need to “breaking up gangs and distribution efforts” as a primary way to curb the epidemic.
Of course, the wall is often an issue of contention. Many experts have argued since President Trump proposed this as the key element of his war on opioids that attacking the supply has never worked with preventing the spread of addiction. And even if it did, many believe the wall will do little to prevent drugs from being brought into America from south of the border.
Some experts are still saying this is not a proper plan because while it does allow federal agencies to move grant money, it establishes no immediate funding for a crisis that killed over 64,000 Americans last year.
Meanwhile, the GOP-controlled House of Representatives today narrowly passed a Senate-approved budget resolution 216 to 212, that some experts claim will cause all $1 trillion cut to Medicaid and $500 million cut to Medicare. Many recovery advocates fear that with the ambiguity concerning health care coverage there will not be enough resources in time to provide treatment to those in need.
Some representatives still believe more funding needs to be committed to the issue, while others say that many people struggling with addiction don’t have health insurance and that more must be done to expand coverage.
The chairman of President Trump’s opioid commission Chris Christie commended the president, calling his announcement a “bold action” to address the opioid crisis. The opioid commission will present a comprehensive plan next week with the final report on November 1st.
No matter what your opinion at this point, we can all agree we need to be moving forward. This means taking an honest look at what is working and what isn’t. Still, the fact that the highest office in the nation has taken the time to address the issue in such terms is hopefully a sign of dramatic change on the way. Only time will tell how this latest move from President Trump will truly impact the opioid epidemic. For now, there is sure to be plenty of debate over the weight of today’s statements and how they will influence policy. There are some promises to be kept, for sure.
There is a lot more to this conversation, but for now, we have to hope that some of these new opportunities will give options and hope to those in America suffering tragically. The opioid crisis is nothing we can expect to be fixed by one person overnight. We have to continue to provide resources to those in need. Palm Healthcare Company facilities have proudly provided addiction treatment resources for decades to those in need. If you or someone you love is struggling, please call toll-free now.
CALL NOW 1-888-922-5398
Back in August, the Commission on Combating Drug Addiction and the Opioid Crisis began urging President Trump to declare a national public health emergency to combat the opioid crisis that has crippled countless communities around America. While the President did soon enough say that he believed the opioid epidemic was indeed a national emergency, the actual official process has yet to begin. However, just this week news broke that President Trump will soon formally declare the “national emergency” status of the opioid crisis.
Reports indicate President Trump plans to make the official declaration next week. It seems appropriate following the explosive exposé following the story on ’60 Minutes’ of former DEA agent Joe Rannazzisi pointing a finger at Big Pharma companies, Congress, and lobbyists for fueling the opioid epidemic.
In fact, Republican Representative Tom Marino, who was the top pick for the Trump administrations Drug Czar, was name-dropped in a less than flattering light in the ’60 Minutes’ piece. Reports today now show Marino has withdrawn from consideration following the story.
So what does this newest revelation mean for combatting the opioid crisis?
One of the initial reasons for declaring a national emergency is pretty straight-forward; raising awareness. Not that we don’t see enough shocking news stories or warnings from local officials being issued in various states, but more attention on the issue will help channel more resources into actually helping address it.
As the commission states in their report:
“It would also awaken every American to this simple fact: if this scourge has not found you or your family yet, without bold action by everyone, it soon will,”
“You, Mr. President, are the only person who can bring this type of intensity to the emergency, and we believe you have the will to do so and to do so immediately.”
When the President of the United States says something is a priority, people take notice. Regardless of whether people always agree on politics, when we can all get behind a major issue and put effort into a more inclusive conversation, there is a better chance more can be done.
Overcoming Addiction Stigma
One of the most important aspects of fighting addiction is overcoming the addiction stigma itself. Many people who are suffering do not get the help they need because they are afraid of the stereotypes associated with drug abuse. A lot of people still doubt what the majority of the medical and scientific communities have adopted as fact; that addiction is a health issue, not a moral failing.
By declaring the opioid crisis a national emergency, President Trump has an opportunity to promote education along with public awareness. The more we can help people to understand how addiction affects the mind and body, the better odds we have of supporting those struggling with compassionate and effective treatment options.
Funding for Fighting Opioids
Perhaps one of the biggest hopes for many addiction recovery advocates is that by President Trump declaring the opioid crisis a national emergency he will influence lawmakers to allocate more funding to resources combatting addiction.
A federal declaration would also allow the government to pull funding from other areas as well, such as funding used for the Public Health Emergency Fund, or even the federal Disaster Relief Fund. So while America has been struck pretty hard by hurricanes and natural disasters, some of this same funding may end up going toward creating addiction resources.
One thing many are hoping is that these new funds will also go to promoting more addiction treatment options across the country. Some states may pursue incentives for performance-based enhanced care management (ECM) program, like one recently implemented in New Jersey. Others may put those resources into prevention and education initiatives.
One thing should seem pretty clear; treatment options should be a priority. We already know we cannot arrest our way out of this problem. The War on Drugs did not work, and many do not expect it will now either. With President Trump declaring the national emergency, hopefully, the new effort will go into protecting mental health and substance abuse parity with healthcare and insurance providers. If we have more ways to help those already desperately in need, we could see a better chance for a way out.
With the CDC stating an estimated 91 Americans dying every single day from opioid-related death, which many experts believe is grossly underreported, helping more people fighting opioid addiction find a way out is crucial. However, we should not wait on politicians, health officials or anyone else to fix it. Recovery takes action. If you or someone you love is struggling, please call toll-free now. We want to help.
CALL NOW 1-888-922-5398
(This content is being used for illustrative purposes only; any person depicted in the content is a model)
Palm Healthcare knows the importance of addressing the multi-faceted needs of the individual who suffers from chronic pain. This is why we created the Pain Recovery Program. A person in pain is not only concerned about reclaiming their own sense of well-being and functioning. They are also concerned about reclaiming their sense of purpose, independence, and direction to life.
Palm Healthcare Pain Recovery Program
The focus of the Pain Recovery Program is assisting that person in pain in reclaiming all aspects of their life. Palm Healthcare utilizes a comprehensive bio-psychosocial perspective while incorporating the latest holistic, traditional, and state of the art, non-invasive technology and interventions.
Individuals participating in The Pain Recovery Program are provided a variety of treatment options that include:
- Medication management
- Nutraceutical (vitamin) therapy
- Physical therapy
- Strength and conditioning
- Muscle manipulation therapy
- Chiropractic care
- Aquatic therapy
Each person in The Pain Recovery Program will receive a personalized treatment plan based on comprehensive evaluations and the specific needs of the individual and their specific needs.
Connecting Pain and Addiction
Part of overcoming pain while overcoming addiction is understanding how the two are so closely related. Patients who are struggling with one or both of these conditions often report adverse symptoms such as:
Chronic pain and substance use disorder (SUD) have similar physical, social, emotional, and economic effects on health and well-being; one can easily be confused for the other, while both can exacerbate each other.
Pain in the Brain
Chronic pain and addiction actually have many of the same exact neurophysiological patterns.
For instance: Chronis pain involves abnormal neural processing. Coincidentally, addiction results when normal neural processes are altered into dysfunctional patterns, including disruptions in:
The truth is, there is still a lot to learn about both of these conditions, including patterns of severity, the course of development and responses to treatment.
Gauging and effectively addressing emotional responses is also crucial to effective and lasting pain treatment.
Pain and Emotions
Continued pain can also cause emotional responses, such as:
- Depressive symptoms
Each of these experiences can even turn into more pain. Even after these psychological causes have been addressed the feedback effect can still cause pain in the body.
In fact, there are many studies that indicate pain treatment has worse outcomes when depression is a factor. Some experts say you can even predict how a pain syndrome will evolve based on the emotional status of the patient.
Emotions and SUD
With substance use disorder, the individual’s emotional state is a core cause of continuous drug use. People who use drugs often experience these same emotional responses like anxiety and depression as a result of isolation, social and professional hardships and other side-effects of their drug use. Not to mention the way certain drugs impact the brain. Emotional and psychological trauma can be just as severe for these individuals as physical trauma.
On the other hand, some people may already have a history of experiencing these emotional difficulties and actually be trying to treat themselves by abusing drugs. This feeds into the cycle of emotional distress and substance use.
Both addiction and chronic pain fluctuate in intensity with time under different circumstances. Depending on what is going on in someone’s life, their pain may get worse or seem to disappear, just like an addiction may seem controllable for a time before hitting another harsh bottom.
Both often require ongoing management. But the difficulty can also be that these two conditions feed into each other in a very complicated, and at times toxic, relationship.
Treatment for one can either support or conflict with the other.
The Painful Cycle of Addiction
One of the many difficulties many people experience when trying to overcome addiction while struggling with chronic pain syndrome is that there is a cycle of pain- drugs- more pain- more drugs that seems inescapable.
For example- Narcotic medication typically prescribed for chronic pain may be an issue for someone with a history of substance use disorder.
But then if someone uses a narcotic prescription pain medication, such as opioid analgesics, it can create a physical dependence. Then when the substance is absent from the body the withdrawal symptoms set in.
Withdrawal and Pain
Withdrawal symptoms frequently lead to an increase in symptoms of anxiety and depression, while creating even more physical pain. In turn, the anxiety and depression from withdrawal can contribute to that pain even further.
This pain and distress can provoke a severe obsession with whatever substance the individual was relying on to provide relief. In other words, the individual will crave the drug even more because they are not only experiencing the psychological distress from their brain lacking the drug, they are also experiencing a magnified sense of pain from the experience as well.
Again, the cycle of pain- seeking relief from the pain through substances- recurring pain- continued substance use making the problem worse. The Pain Recovery Program is about interupting this self-destructive cycle with new, sustainable methods of pain management.
The Importance of Treating Pain and Addiction
Substance use disorder in relation to prescription pain medication is widely misunderstood, and while some programs focus on treating the addiction, if there is no way of addressing the chronic pain it does not help the chances of successful recovery. Part of working with chronic pain patients struggling with addiction is education on both conditions while providing effective treatment opportunities simultaneously.
Providing pain management opportunities for the U.S. population struggling with substance use disorder is a unique challenge for many primary care physicians. That is why experienced professionals in the field of drug and alcohol addiction treatment are in a unique position to help.
First, we need to acknowledge a few issues, including:
- People recovering from addiction experiencing pain are less likely to receive adequate pain management than anyone else.
- Insufficient pain relief is a substantial risk factor for possible relapse into substance use.
- It is crucial to distinguishing between patients who are seeking relief for legitimate pain and those who are seeking pain medication for recreational abuse
- Psychiatric and medical illnesses can complicate effective pain management
Experts believe that addiction specialists, in particular, can make significant contributions to the management of chronic pain in patients who suffer from substance use disorder. Addiction specialists can:
- Help create safeguards to assure any pain medication is taken appropriately
- Reinforce behavioral and self-care components of pain management
- Help individuals with strategies to reduce stress
- Assess patients’ recovery support systems
- Help to understand and identify relapse risks
Chronic pain management can be a complex process. Experts say that the efficiency of treatment is amplified when all medical and behavioral healthcare professionals involved collaborate as a team. Palm Healthcare Company’s Pain Recovery Program is all about a united effort toward treating both conditions with a variety of experienced professionals and trainers.
Considering how urgent the addiction epidemic is, and the fact that many people struggling with addiction do suffer from chronic pain, it is so important to have programs like this available. Education, support and relapse prevention is the key. If your or someone you love is struggling with substance use disorder and chronic pain, please call toll-free now. We want to help.
CALL NOW 1-888-922-5398